BioCentury | Oct 8, 2019
Company News
Management tracks: BioMarin's first chief scientific strategy officer; plus Ascletis, Grail, Aerie and more
...and Co. (NYSE:LLY). Gregory is chair and CEO of Isometry Advisors Inc. Therapeutic toxin company Aeon Biopharma Inc....
...Writer BioMarin Pharmaceutical Inc. Ascletis Pharma Inc. Grail Inc. Aerie Pharmaceuticals Inc. Verrica Pharmaceuticals Inc. Biodesix Inc. Nurix Therapeutics Inc. Alphaeon Corp. Relay Therapeutics Inc. Aeon Biopharma Inc....
...Writer BioMarin Pharmaceutical Inc. Ascletis Pharma Inc. Grail Inc. Aerie Pharmaceuticals Inc. Verrica Pharmaceuticals Inc. Biodesix Inc. Nurix Therapeutics Inc. Alphaeon Corp. Relay Therapeutics Inc. Aeon Biopharma Inc....
